AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

EMPYREAN ENERGY PLC

Director's Dealing Mar 13, 2017

7622_rns_2017-03-13_4e40216f-4928-41d6-a939-8bf324e65a93.html

Director's Dealing

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 2649Z

Empyrean Energy PLC

13 March 2017

This announcement contains inside information

Empyrean Energy Plc / Index: AIM / Epic: EME / Sector: Oil & Gas

13 March 2017

Empyrean Energy PLC ('Empyrean' or 'the Company')

Option Purchase and Exercise

Empyrean confirms that it was notified that on 10 March 2017 that Apnea Holdings Pty Ltd ("Apnea"), a company which is wholly-owned by Tom Kelly, CEO of Empyrean, on that date purchased options (the "Options") in respect of 63,000,000 ordinary shares of 0.2p each in in the Company ("Ordinary Shares") from a third party not connected with the Company (the "Seller"). The terms of the Options are set out below and the total consideration payable by Apnea in respect of the purchase of the Options was AU$275,000 (equivalent to approximately £171,000).

Number of Options Exercise Price Expiry Date
18,000,000 0.2 pence 19 July 2017
15,000,000 2.1 pence 19 July 2017
15,000,000 4.1 pence 25 March 2018
15,000,000 2.1 pence 26 July 2019

Further to the announcement on 15 December 2016, the first tranche of Options detailed above reflects the agreement reached between the Company and the Seller that, if this tranche of Options were to be exercised prior to shareholder approval being granted for the necessary capitalisation from reserves to allow the exercise price to be amended to 0.1p, then this tranche of Options would  have an exercise price of 0.2p and convert into a greater number of 18,000,000 Ordinary Shares.

Empyrean also announces that, on 10 March 2017, it received notice from Apnea that it intended to exercise its option in relation to 18,000,000 Ordinary Shares at an exercise price of 0.2 pence each. Accordingly, the Company has issued and allotted 18,000,000 Ordinary Shares (the "New Ordinary Shares").  Application will be made for the New Ordinary Shares to be admitted to trading on AIM.  Admission is expected to take place on 17 March 2017. These New Ordinary Shares will rank pari passu with the existing Ordinary Shares.

Following this exercise, Tom Kelly has a beneficial interest in 38,881,563 Ordinary Shares, representing 16.21% per cent. of the enlarged issued share capital of the Company.

Following the transaction, Empyrean's total issued share capital will comprise 239,833,853 Ordinary Shares, each with voting rights. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, securities of the Company under the Financial Conduct Authority's Disclosure and Transparency Rules.

**ENDS**

Empyrean Energy plc
Tom Kelly Tel: +61 8 9481 0389
Cenkos Securities plc
Neil McDonald Tel: +44 (0) 131 220 9771
Beth McKiernan Tel: +44 (0) 131 220 9778
Nick Tulloch Tel: +44 (0) 131 220 9772
St Brides Partners Ltd
Elisabeth Cowell Tel: +44 (0) 20 7236 1177
Lottie Brocklehurst Tel: +44 (0) 20 7236 1177

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1. Details of the person discharging managerial responsibilities / person closely associated
a) Name Tom Kelly
2. Reason for the Notification
a) Position/status Chief Executive Officer of the Company
b) Initial notification/amendment Initial notification
3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a) Name Empyrean Energy plc
b) LEI -
4. Details of the transaction(s):section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv)each place where transactions have been conducted
a) Description of the Financial instrument, type of instrument Options over ordinary shares of 0.2p each ("Ordinary Shares")
Identification code GB00B09G2351
b) Nature of the Transaction Purchase of options in respect of 63,000,000 Ordinary Shares and subsequent exercise of options in respect of 18,000,000 Ordinary Shares at 0.2p per Ordinary Share.
c) Price(s) and volume(s) Price Volume
AU$275,000 (aggregate) (equivalent to approximately £171,000) Options in respect of 63,000,000 Ordinary Shares with an exercise price of 0.2p to 4.1p per Ordinary Share
Price Volume
0.2p 18,000,000
d) Aggregated information

Aggregated volume Price
N/A (Single transaction)
e) Date of the transaction 13 March 2017
f) Place of the transaction London Stock Exchange, AIM (LON:EME)

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHMMGMFGFRGNZM

Talk to a Data Expert

Have a question? We'll get back to you promptly.